ONCY (Oncolytics Biotech, Inc. Common Shares) Stock Analysis - Hedge Fund Holdings
Oncolytics Biotech, Inc. Common Shares (ONCY) is a publicly traded Healthcare sector company. As of May 21, 2026, ONCY trades at $0.84 with a market cap of $92.91M and a P/E ratio of -2.77. ONCY moved +6.72% today. Year to date, ONCY is -15.03%; over the trailing twelve months it is +90.83%. Its 52-week range spans $0.33 to $1.53. Analyst consensus is strong buy with an average price target of $6.00. Rallies surfaces ONCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ONCY stock?
Hedge funds tracked by Rallies that own ONCY include Citadel Advisors and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Oncolytics Biotech, Inc. Common Shares.
ONCY Key Metrics
Key financial metrics for ONCY
Metric
Value
Price
$0.84
Market Cap
$92.91M
P/E Ratio
-2.77
EPS
$-0.30
Dividend Yield
0.00%
52-Week High
$1.53
52-Week Low
$0.33
Volume
147
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-28.76M
Gross Margin
0.00%
Top Hedge Funds Holding ONCY
Citadel Advisors holds 79.25K shares of ONCY, changed -42.19% as of Sep 30, 2024.
Two Sigma holds 14.08K shares of ONCY, changed +19.15% as of Sep 30, 2024.
Hedge funds tracked by Rallies that own ONCY include Citadel Advisors and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Oncolytics Biotech, Inc. Common Shares.
Does Rallies show 13F holders for ONCY?
Yes. Rallies tracks hedge fund and 13F ownership data for ONCY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ONCY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ONCY. It does not provide personalized investment advice.
